Peter Dannenbaum | VP, IR |
Robert Davis | President, CEO & Director |
Caroline Litchfield | EVP & CFO |
Dean Li | EVP & President;, Merck Research Laboratories |
Evan Seigerman | BMO Capital Markets |
Andrew Baum | Citigroup |
Louise Chen | Cantor Fitzgerald & Co. |
Carter Gould | Barclays Bank |
Seamus Fernandez | Guggenheim Securities |
Geoffrey Meacham | Bank of America Merrill Lynch |
Umer Raffat | Evercore ISI |
Mara Goldstein | Mizuho Securities |
Ladies and gentlemen, thank you for standing by. Good morning. My name is Alan, and I will be your conference moderator today. At this time, I would like to welcome everyone to the Merck & Company Q2 Sales and Earnings Conference Call. [Operator Instructions].